Skip to main content

Table 9 Multivariate analysis for COPD re‑admission with a 2-year follow-up

From: The predictive value of baseline symptom score and the peripheral CD4CD8 double-positive T cells in patients with AECOPD

Variables

B

P

OR

95% C.I. for OR

Min

Max

Home oxygen therapy

0.80

0.07

2.22

0.92

5.37

SGRQ score

-0.006

0.75

0.99

0.96

1.03

mMRC score

0.15

0.71

1.16

0.53

2.57

Inhaled COPD therapy

-

0.40

-

-

-

No inhaled treatment

-

-

1

-

-

LAMA

1.07

0.29

2.92

0.40

21.01

ICS + LABA

0.53

0.54

1.70

0.31

9.22

LABA + LAMA

1.46

0.10

4.31

0.77

24.10

ICS + LABA + LAMA

1.20

0.11

3.32

0.77

14.20

Exercise capacity score

0.01

0.98

1.01

0.34

2.93

CAT score

0.02

0.71

1.02

0.91

1.14

COPD-related exacerbation within the previous year

0.51

0.02

1.67

1.09

2.55

CD4+CD8+ T cells%

-0.45

0.10

0.64

0.37

1.08

Constant

-2.18

0.03

0.11

  
  1. Binary logistic regression was used
  2. OR odds ratio, CI confidence interval, Max maximum, Min minimum, COPD chronic obstructive pulmonary disease, SGRQ St George's respiratory questionnaire, mMRC modified medical research council, CAT chronic obstructive pulmonary disease assessment test, LAMA Long-acting muscarinic antagonists, LABA long-acting beta2-agonists, ICS inhaled corticosteroids